I'd agree and I hope they choose to use Syneos Hea
Post# of 146044
![](/assets/46931549/no_avatar_available_thumb.jpg)
I corrected the post and thanks once again.
I'm glad I can converse again with you.
One thing I realized today was that Avastin is off patent and this means Genentech/Roche won't benefit from the MSS mCRC trial.
This is making me think Dr. Lalezari wants to do MSS mCRC alone. After all, who can we partner with on such a trial when all the combining medications are off patent?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)